New report says this biotech could run over 337%
We are keeping a close eye on this tiny biotech stock.
This little-known company already has 14 patents – and they are pioneering a new type of therapeutic treatment for Cancer patients.
Maybe that's why one of Wall Street's leading analysts recently predicted this stock could run 300% within the next 12-months.
Click Here for Full Report and Ticker Symbol
If you no longer wish to receive our emails, click the link below:
Unsubscribe
DailyMarketAlerts 315 Ridgedale Avenue #556 East Hanover, New Jersey 07936 United States
Post a Comment
Post a Comment